by Alex Bajjon | Mar 4, 2022 | UK
Background Neurim previously sued Mylan for infringement in the UK of its European patent no. 1441702, which is related to melatonin for use in improving the sleep quality of a patient suffering from primary insomnia characterised by non-restorative sleep. Mylan...
by Eddie Bishop | Feb 15, 2022 | Briefings, EPO
Background In 2018, two patent applications (EP3564144 and EP3563896) were filed by the same applicant, Dr Thaler, and initially failed to provide information about the inventor. After notification from the EPO regarding the missing inventor details, the applicant...
by Sean HutchinsonEddie Bishop | Feb 8, 2022 | EPO
Background In our previous article, we discussed the expected referral to the Enlarged Board of Appeal in case T 116/18, wherein the Board of Appeal decided greater clarity was required concerning the use of post-published data when considering inventive step. The...
by | Oct 1, 2021 | Briefings
Background Dr Thaler filed two UK patent applications and subsequently filed Form 7’s stating that the inventor for both applications was the AI system “DABUS”. Dr Thaler also indicated on the Form 7’s that he had acquired the right to be...
by Sean Hutchinson | Oct 1, 2021 | Briefings, US & International
Background In 2008, the State Council of China issued its “Outline of the National Intellectual Property Strategy”, which set a target of increasing the administration and use of IP rights in China by 2020. Last year, the State Council Information Office...
Recent Comments